Coagulation cascade factor

Coagulation cascade factors are a series of plasma proteins, primarily serine proteases and cofactors, that drive hemostasis via amplified, stepwise activation, ultimately converting fibrinogen to fibrin to form a stable clot. They are traditionally divided into intrinsic, extrinsic, and common pathways, though modern understanding emphasizes their cellular context and regulation. These proteins are central to the physiological balance between bleeding and thrombosis and are major therapeutic targets for anticoagulants, replacement therapies, and diagnostics. Dysregulation, whether genetic or acquired, leads to a spectrum of bleeding and thrombotic disorders. Their activity is closely monitored with laboratory assays such as PT, aPTT, and D-dimer[2][4][5][6][7]. Note: For therapeutic targeting, it is usually necessary to specify individual factors by name (e.g., "Factor Xa," "Thrombin") rather than the generic "coagulation cascade factors."[2][5][7]

Other names

Clotting factorsblood coagulation factorscoagulation factors

Inhibition of specific coagulation factors (e.g., factor Xa, thrombin); Augmentation/replacement with recombinant factors for deficiencies; Vitamin K antagonism (inhibition of carboxylation needed for function of factors II, VII, IX, X)